Company Profile

SAMDI Tech is an early-stage technology company based on the pioneering research from the laboratory of Professor Milan Mrksich. The Company offers unique assay capabilities that are commercially available through our contract assay services. The assay platform, SAMDI, combines mass spectrometry (MS) with high-density arrays for rapid and quantitative measurement of analytes in biochemical reactions. Our approach to screening enzyme activities eliminates the caveats of labeled methodologies that include: reducing rates of false positives and negatives, shortening assay development times, and screening in a high-throughput format. Our SAMDI assay services can help provide a better understanding of biological function and aid in the discovery of early stage modulators of enzymes involved in human disease.